First conjugates based on a Sigma receptor modulator and a proteasome-impairing agent. Design, synthesis and exploratory biological evaluation in cancer cells
Elsevier ·
Аннотация у издателя не опубликована — полный текст доступен по ссылке ниже.
First conjugates based on a Sigma receptor modulator and a proteasome-impairing agent. Design, synthesis and exploratory biological evaluation in cancer cells. // European Journal of Medicinal Chemistry. – URL: https://www.sciencedirect.com/science/article/pii/S0223523426009360?dgcid=rss_sd_all
First conjugates based on a Sigma receptor modulator and a proteasome-impairing agent. Design, synthesis and exploratory biological evaluation in cancer cells. European Journal of Medicinal Chemistry. https://www.sciencedirect.com/science/article/pii/S0223523426009360?dgcid=rss_sd_all
“First conjugates based on a Sigma receptor modulator and a proteasome-impairing agent. Design, synthesis and exploratory biological evaluation in cancer cells.” European Journal of Medicinal Chemistry.
@article{article74035,
title = {First conjugates based on a Sigma receptor modulator and a proteasome-impairing agent. Design, synthesis and exploratory biological evaluation in cancer cells},
journal = {European Journal of Medicinal Chemistry},
url = {https://www.sciencedirect.com/science/article/pii/S0223523426009360?dgcid=rss_sd_all}
}